1. Yes they do. The development agreement specifically states that if Teva were to give MSB a 'decision notice' to withdraw from funding the trial, they have to hand back all of the IP.
2. The trial wasn't redesigned to take into account the different catheter, it was redesigned to target a different endpoint so they could make number of enrolled subjects smaller. That's directly from Silviu in the video.
You really don't know much about this company do you dolce?
1. Yes they do. The development agreement specifically states...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |